|
The Foundation’s Board of Directors is composed of business and community leaders as well as healthcare professionals from the NAMS membership who have expressed a substantial interest in furthering the Mission
of NAMS through active fund development initiatives. The NAMS Foundation Board of Directors is composed of
the following:
 |
PRESIDENT
Arthur H. Bill Professor Emeritus of Reproductive Biology
Case Western Reserve University School of Medicine
Chairman, Advisory Board, Rapid Medical Research
Consultant, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic
Executive Director, The North American Menopause Society
Cleveland, OH
View Disclosure |
 |
VICE PRESIDENT
Founder & Chairman Emeritus—Experient
Founder—PlanSoft (now On-vantage)
Founder—Experient
Inductee—Hall of Leaders, Convention Industry Council
Twinsburg, OH
View Disclosure
|
 |
SECRETARY
Community Leader; Philanthropist
Lyndhurst, OH
View Disclosure
|
 |
TREASURER
Professor and Dean Emeritus
Family and Child Nursing
University of Washington School of Nursing
Seattle, WA
View Disclosure
|
 |
NAMS 2009-2010 PRESIDENT
Clinical Professor of Medicine
University of California, San Diego
9500 Gilman Drive, Suite 0659
La Jolla, CA
View Disclosure
|
 |
Professor Emerita and Dean Emerita
College of Nursing
Michigan State University
East Lansing, MI
View Disclosure
|
 |
Attorney and Managing Partner
Margaret W. Wong & Associates Co., LPA
Cleveland, OH
View Disclosure
|
The NAMS Foundation Board of Directors reports the following list of all financial relationships:
Mr. Harris reports: No significant financial relationships.
Mrs. Ratner reports: No significant financial relationships.
Dr. Rothert reports: No significant financial relationships.
Dr. Stuenkel reports: Consultant/Advisory Board: Eli Lilly, Upsher Smith, Wyeth; Stock/Shareholder: Abbott Laboratories, Johnson & Johnson; Speaker’s Bureau: Boston Scientific, CHF Solutions, GlaxoSmithKline, J&J Scios, Medtronic
Dr. Utian reports: Consultant/Advisory Board: Bionovo, Depomed, Duramed, KV Pharmaceuticals, Eli Lilly, Merck, Novartis, Orcas Therapeutics, QuatRx
Ms. Wong reports: No significant financial relationships.
Dr. Woods reports: No significant financial relationships. |